Silymarin for the Prevention of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction - Egyptian Knowledge Bank - troweb

415889

Silymarin for the Prevention of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction

Article

Last updated: 09 Mar 2025

Overview Similar Items

Article

Silymarin: A promising cardioprotective agent

Article

Pre-Contrast Hemogram-Derived Indices as Predictors for Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention

Article

Risk Factors of Contrast-Induced Nephropathy after Percutaneous Coronary Interventions: An Observational Study

Article

THE EFFECT OF ADMINISTRATION OF ASCORBIC ACID IN PREVENTION OF CONTRAST INDUCED NEPHROPATHY IN PATIENTS WITH RENAL IMPAIRMENT UNDERGOING CORONARY INTERVENTION

Article

CHADS2-VASC Score as a Predictor for Contrast Induced Nephropathy in Patient with Acute Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention

Article

Doxorubicin-induced cardiotoxicity in mice; protection by silymarin

Article

Comparative cardioprotective effect of Egyptian Silybum marianum extract and Chinese silymarin in experimentally liver fibrosis.

Article

The value of De Ritis ratio in patients undergoing percutaneous coronary intervention for prediction of contrast-associated acute kidney injury

Article

Microalbuminuria as a Predictor of Outcome in Non-Diabetic Patients Undergo Percutaneous Coronary Intervention for Acute Coronary Syndrome

Article

Serum Kidney Injury Molecule-1 and Cytochrome C as Biomarkers for Early Detection of Contrast-Induced Nephropathy in Elderly Patients with ST-Elevation Myocardial